Pope Francis is eating and intravenous feeding has never been mentioned, the Vatican said as he continues to battle pneumonia ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

Switching from established intravenous (IV) therapy to subcutaneous infliximab was associated with high treatment persistence, stable clinical disease activity, and consistent faecal calprotectin ...

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

The following is a summary of “Discarded intravenous medication in the ICU: the GAME-OVER multicenter prospective observational study,” published in the February 2025 issue of Critical Care by ...

People can take these orally or through an intravenous (IV) line. Medicare helps pay for chemotherapy deemed medically necessary. How a person receives the treatment and in what setting determines ...

After patients had undergone a 3-week run-in of subcutaneous darbepoetin alfa, they were randomized 1:1 to receive either subcutaneous or intravenous darbepoetin alfa once a week for 20 weeks ...

Scientists at the Icahn School of Medicine at Mount Sinai have developed a lipid nanoparticle system capable of delivering messenger RNA (mRNA) to the brain via intravenous injection, a challenge ...

our study was limited by low power to detect an effect in a small but clinically important fraction of patients receiving the combination of high-dose intravenous calcium and concurrent ceftriaxone.

In this randomized trial, intraosseous-first vascular access did not result in higher 30-day survival than intravenous-first ...